Bone Marrow Transplant
Bone Marrow Transplant is a biological therapy with 15 clinical trials. Currently 1 active trials ongoing. Historical success rate of 83.3%.
Success Metrics
Based on 10 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
7
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
71.4%
10 of 14 finished
28.6%
4 ended early
1
trials recruiting
15
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
HIV Antigen-specific T-cells Targeting Conserved Epitopes (HST-NEETs) BMTCTN1903
Cryopreserved MMUD BM With PTCy for Hematologic Malignancies
Delayed Tolerance Through Mixed Chimerism
HLA Haploidentical Bone Marrow Transplant in Patients With Severe Sickle Cell Disease
Comparing Autologous Peripheral Blood Stem Cell to Bone Marrow Transplantation for Recurrent Non-Hodgkin's Lymphoma
Clinical Trials (15)
HIV Antigen-specific T-cells Targeting Conserved Epitopes (HST-NEETs) BMTCTN1903
Cryopreserved MMUD BM With PTCy for Hematologic Malignancies
Delayed Tolerance Through Mixed Chimerism
HLA Haploidentical Bone Marrow Transplant in Patients With Severe Sickle Cell Disease
Comparing Autologous Peripheral Blood Stem Cell to Bone Marrow Transplantation for Recurrent Non-Hodgkin's Lymphoma
Transplantation of Partially Mismatched Related or Matched Unrelated Bone Marrow for Patients With Refractory Severe Aplastic Anemia
CD34+ Enriched Transplants From HLA-Compatible Patients With Hematologic Malignancies
An Open Trial Combining Zidovudine, Interferon-alfa, and Recombinant CD4-IgG With Transplantation of Syngeneic Bone Marrow and Peripheral Blood Lymphocytes From Healthy gp160-Immunized Donors in the Treatment of Patients With HIV Infection
Allogeneic Stem Cell Transplantation in Chronic Myeloid Leukemia Failing TKIs Therapy
Shorter Course Tacrolimus After Nonmyeloablative, Related Donor BMT With High-dose Posttransplantation Cyclophosphamide
BMT and High Dose Post-Transplant Cyclophosphamide for Chimerism Induction and Renal Allograft Tolerance
Bone Marrow Transplant Trial for Patients With Refractory Severe Aplastic Anemia
Blood and Marrow Transplant Clinical Research Network
Marrow Mesenchymal Cell Therapy for Osteogenesis Imperfecta: A Pilot Study
Conditioning Regimens for Patients With Severe Aplastic Anemia Transplanted With Marrow From an Unrelated Donor
All 15 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 15